Benzinga's Top Upgrades, Downgrades For October 5, 2017

Top Upgrades

  • Morgan Stanley upgraded Regal Entertainment Group RGC from Underweight to Equal-Weight. Regal Entertainment shares gained 1 percent to $17.09 in pre-market trading.
  • Stephens & Co. upgraded BB&T Corporation BBT from Equal-Weight to Overweight. BB&T shares fell 1.09 percent to close at $46.37 on Wednesday.
  • Morgan Stanley upgraded T. Rowe Price Group Inc TROW from Underweight to Equal-Weight. T. Rowe Price shares gained 0.54 percent to close at $91.41 on Wednesday.
  • Analysts at Baird upgraded AmerisourceBergen Corp. ABC from Neutral to Outperform. AmerisourceBergen shares fell 0.17 percent to close at $82.74 on Wednesday.
  • Canaccord Genuity upgraded Microsoft Corporation MSFT from Hold to Buy. Microsoft shares rose 0.95 percent to $75.40 in pre-market trading.
  • Bank of America upgraded Sherwin-Williams Co SHW from Underperform to Buy. Sherwin-Williams shares gained 0.78 percent to $377.08 in pre-market trading.
  • Morgan Stanley upgraded Biogen Inc BIIB from Equal-Weight to Overweight. Biogen shares rose 2.15 percent to $321.70 in pre-market trading.
  • Analysts at Raymond James upgraded East West Bancorp, Inc. EWBC from Underperform to Market Perform. East West Bancorp shares fell 1.89 percent to close at $58.72 on Wednesday.


Top Downgrades

  • Analysts at Morgan Stanley downgraded Celgene Corporation CELG from Equal-Weight to Underweight. Celgene shares fell 2.71 percent to $142.55 in pre-market trading.
  • Piper Jaffray downgraded Coach Inc COH from Overweight to Neutral. Coach shares dropped 1.28 percent to $39.21 in pre-market trading.
  • Oppenheimer downgraded CarMax, Inc KMX from Outperform to Perform. CarMax shares fell 1.18 percent to $75.55 in pre-market trading.
  • Canaccord Genuity downgraded Mallinckrodt PLC MNK from Buy to Hold. Mallinckrodt shares slipped 2.28 percent to $36.51 in pre-market trading.
  • Jefferies downgraded RPC, Inc. RES from Buy to Hold. RPC shares fell 0.54 percent to $23.95 in pre-market trading.
  • Stifel Nicolaus downgraded Momenta Pharmaceuticals, Inc. MNTA from Buy to Hold. Momenta Pharmaceuticals shares declined 2.35 percent to $14.74 in pre-market trading.
  • Deutsche Bank downgraded Western Digital Corp WDC from Buy to Hold. Western Digital shares declined 2.2 percent to $82.50 in pre-market trading.
  • Analysts at Citigroup downgraded GrubHub Inc GRUB from Buy to Neutral. GrubHub shares slipped 1.77 percent to $53.14 in pre-market trading.
  • Stephens & Co. downgraded PNC Financial Services Group Inc PNC from Overweight to Equal-Weight. PNC Financial shares rose 0.07 percent to close at $134.27 on Wednesday.
  • Compass Point downgraded Navient Corp NAVI from Buy to Neutral. Navient shares declined 1.74 percent to close at $14.70 on Wednesday.


Top Initiations

  • Analysts at Pivotal Research initiated coverage on Nike Inc NKE with a Hold rating. The price target for Nike is set to $56. Nike shares closed at $52.08 on Wednesday.
  • Oppenheimer initiated coverage on Gilead Sciences, Inc. GILD with a Perform rating. Gilead Sciences shares closed at $82.42 on Wednesday.
  • Analysts at Mizuho initiated coverage on FibroGen Inc FGEN with a Neutral rating. The price target for FibroGen is set to $61. FibroGen shares closed at $60.10 on Wednesday.
  • Deutsche Bank initiated coverage on DowDuPont Inc DWDP with a Buy rating. The price target for DowDuPont is set to $80. DowDuPont shares closed at $70.45 on Wednesday.
  • Pivotal Research initiated coverage on VF Corp VFC with a Buy rating. The price target for VF Corp is set to $75. VF Corp shares closed at $64.91 on Wednesday.
  • Jefferies initiated coverage on Keane Group Inc FRAC with a Buy rating. The price target for Keane Group is set to $20. Keane Group shares closed at $17.01 on Wednesday.
  • Analysts at Mizuho initiated coverage of Akebia Therapeutics Inc AKBA with a Buy rating. The price target for Akebia Therapeutics is set to $24. Akebia Therapeutics shares closed at $19.23 on Wednesday.
  • Analysts at Pivotal Research initiated coverage on Under Armour Inc UAA with a Hold rating. The price target for Under Armour is set to $17. Under Armour shares closed at $16.47 on Wednesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationAnalyst RatingsDowngradesInitiationstop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!